Top Markets
Coin of the day
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Ранг среди акций #40630
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Цена акции
$0.00045794
Последняя синхронизация: 2025-07-11
Рыночная капитализация
$107.51K
Изменение (1 день)
-36.01%
Изменение (1 год)
0.00%
Страна
DK
Торговля Scandion Oncology A/S (SCOL)

Категория

История цены акций Scandion Oncology A/S (SCOL)
Наивысшая цена закрытия: $0.00 2025-07-01

Наименьшая цена закрытия: $0.74 2018-11-01
История цены акций Scandion Oncology A/S с 2018 по 2026
Годовая динамика цены акций
Год Результативность
2025 -92.13%
2024 -96.87%
2023 -14.41%
2022 -80.44%
2021 -42.28%
2020 127.83%
2019 80.43%
2018 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$518.36 30.92%
US
$859.40 32.91%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE